Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins

Goldman Sachs reinstated Estée Lauder with a Buy rating and a $100 price target, citing a strengthening turnaround, 300+ bps of year-to-date operating margin expansion, and a return to revenue growth in fiscal 2026 after three down years. The firm expects 4.5% revenue growth in fiscal 2026 and fiscal 2027, with EPS rising to $2.44 in fiscal 2026 from $1.51 a year earlier, supported by improving China trends and a less volatile travel retail business. Goldman also sees roughly 450 bps of EBIT margin expansion through fiscal 2029, though it flagged execution and demand risks.

Analysis

EL looks less like a simple multiple expansion story and more like a leverage reset: if management can keep growth positive while taking fixed costs out, incremental revenue should translate into outsized EPS recovery over the next 4-8 quarters. The key second-order effect is that margin repair at a prestige brand usually improves channel leverage with retailers and distributors, which can widen shelf space and promotional support just as peers are forced to spend more to defend share.

The market is likely still underestimating the quality of the turnaround because travel retail volatility has been a valuation overhang for years; reducing that mix lowers the probability of a future earnings drawdown even if top-line growth is only mid-single-digit. China is the swing factor: if gains there are real rather than cyclical, EL can compound at a materially higher rate than the market is pricing, but any slip in market share would quickly expose how much of the current optimism is based on operating discipline rather than demand acceleration.

For competitors, the pressure is mostly on mid-tier prestige and adjacent beauty names that have not yet retooled their cost bases. A stronger EL can force more aggressive innovation and promo spend across the category, which is bad for gross margin across the space; the likely beneficiaries are suppliers and retailers with exposure to premium beauty mix, while weaker brands may lose distribution priority. The bigger risk is that this is a 6-12 month rerating story rather than a durable franchise reacceleration: if China or travel retail softens, the market will probably punish the stock quickly because expectations are now moving ahead of fundamentals.

Contrarianly, the consensus may be too focused on the optics of multiple reconstruction and not enough on the operating leverage embedded in the savings plan. If cost savings land, EL could outperform simply because consensus EPS revisions will have to catch up faster than revenue estimates, making this more of an estimate revision trade than a pure consumer recovery call.

Key Decisions for Investors

• Long EL on a 3-6 month horizon into the next earnings cycle; favor entry on pullbacks of 5-7% as the market often waits for proof on China before rewarding the rerating. Risk/reward is attractive if margin expansion continues, with downside limited unless growth decelerates materially.
• Structure a call spread in EL (e.g., 3-6 month 90/105) to express upside from estimate revisions while limiting premium burn if the turnaround stalls. Best used if implied volatility remains reasonable after the note-driven move.
• Pair long EL / short a weaker prestige beauty peer or broader discretionary basket over 2-4 quarters to isolate turnaround execution from beta. The trade works if EL’s cost discipline and reduced travel-retail volatility drive relative multiple expansion.
• Use EL as a catalyst trade only if you can confirm China channel data remains constructive for another 1-2 quarters; if market share data rolls over, cut quickly, as the stock will likely derate on any evidence the recovery is front-loaded.
• Avoid chasing at the open; wait for post-research digestion or a market-wide selloff to improve entry. The setup is better on consolidation than on momentum because the story needs several quarters of proof.